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The food industry is playing an increasing role in the development and marketing of new products although little is known regarding the bioavai-
lability of the phytochemicals they contain. Our aim was to assess the effect of the presence of absorption modifiers (milk and iron) on the in vitro
bioaccessibility and the serum response in vivo of carotenoids and a-tocopherol from fruit juices. Thirty-two young women participated in a three-
period (21 d each) supplementation study with a 2-week wash-out in between. Subjects consumed consecutively 2 £ 250 ml/d vitamin C-fortified
juices supplied as fruit juice, fruit juice containing milk and fruit juice containing milk and iron. Fasting blood samples were collected before and
after each supplementation period. In vitro bioaccessibility of carotenoids and a-tocopherol was assessed by a static digestion model. Vitamin E
and carotenoids from both studies were determined by HPLC. In vitro, xanthophyll ester hydrolysis and transference of free xanthophylls and
a-tocopherol into the micellar phase were higher in the presence of absorption modifiers. In vivo, consumption of the fruit juices provoked
significant increments (within-subject) of a-tocopherol and some carotenoids in serum. Dose-adjusted increments in serum of some carotenoids
were higher when subjects consumed juices with milk and milk plus iron, although differences did not reach statistical significance. In conclusion,
the presence of milk and milk plus iron do not influence the bioavailability of carotenoids and a-tocopherol from fruit juices in vivo. Our results
support the use of in vitro models to assess food-related factors affecting bioavailability of carotenoids and tocopherols from foods.
Bioavailability: In vitro digestion: Carotenoids: Human studies
Fruits and vegetables are major sources of biologically active
compounds, many of which, i.e. carotenoids and tocopherols,
may have beneficial effects against chronic diseases(1). To
achieve the benefits associated with the consumption of
fruits and vegetables, different approaches are considered to
increase the content and/or the bioavailability of these com-
ponents including agricultural practices, biotechnology and
food technology(2).
Bioavailability is a critical feature in the assessment of the
role of phytochemicals in human health and approaches to
the study of the bioavailability of food components include
in vitro and in vivo methods. In vitro models based on
human physiology have been developed as simple, inexpen-
sive, non-invasive and reproducible tools to study digestive
stability, micellization, intestinal transport and metabolism,
and to predict the bioavailability of different food com-
ponents (i.e. ascorbic acid, carotenoids, tocopherols and
polyphenols)(3 – 6). Nevertheless, since several factors are
capable of influencing vitamin bioavailability at different
points, in vitro methodology for bioavailability assessment
and its potential predictive value regarding human absorption
of phytochemicals should be validated in different in vivo
situations(7).
Different dietary factors are known to affect the bioavai-
lability of carotenoids and tocopherols in man(8,9). Both the
amount and type of fat affect the bioavailability of some
(i.e. lutein), but not all, carotenoids(10,11), while plant sterols
and water-soluble fibres (i.e. pectin) decrease the absorption
of b-carotene, lycopene, lutein and tocopherols in man(12).
Similarly, in vitro bioaccessibility studies of carotenoids
have also shown positive and negative associations with fat
and fibre content(13,14). In this context, the transfer into
micelles constitutes a key step of carotenoid absorption from
different foods, and different influencing factors have been
reported including soluble and insoluble indigestible fractions,
taurocholate amount, amount and type of lipids and acyl
moieties, the content of Klason lignin and NSP, phospholipids
and bile salt content(5,15 – 19).
Currently, the food industry is playing an increasing
role in the development and marketing of new products
and the addition of milk to fruit-based juices and beverages
is becoming a common practice. Several components simul-
taneously present in foods, such as carotenoids, a-tocopherol
and food-derived peptides (such as casein phosphopeptides,
generated from casein digestion of milk) are bioactive, dis-
playing antioxidant activities(20 – 22) and perhaps interacting
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by different mechanisms during digestion and absorption.
In this sense, milk-derived peptides may inhibit lipid oxi-
dation by chelation and non-chelating mechanisms(23,24),
show cytomodulatory and inmunomodulatory effects and
may bind minerals (i.e. calcium, iron, zinc)(22,25,26), increa-
sing their solubility and displaying a positive effect on
mineral absorption (i.e. calcium, iron), although conflic-
ting results have been reported(27). Thus, because of their
potential beneficial effect on mineral bioavailability and
other biologically relevant activities that they may display,
food-derived peptides are considered as potential func-
tional ingredients in foods(22,28). However, while this may
be relevant for the food quality and stability of micro-
nutrients in foods, little is known regarding the effects on
the bioavailability of phytochemicals. Thus, to understand
better the effect of the presence of absorption modifiers
(milk-derived peptides and iron) on the bioavailability of
carotenoids and a-tocopherol, we used a complementary
approach; an in vitro model to assess pre-absorptive events
(i.e. stability, ester hydrolysis, isomerization, micellarization;
bioaccessibility) and an in vivo study to evaluate the
serum response upon regular consumption of the fruit
juices (bioavailability).
Subjects and methods
Subjects
Thirty-two young women (20–30 years) participated in
a three-period (21 d each) supplementation study with a
2-week wash-out in between. Qualitative and quantitative con-
tent of the juices was approached, based on industrial and
scientific reasons, and the final product specifically developed
for the purpose of the present study (Hero S.A., not commer-
cially available). Juices were prepared according to the proto-
cols and controls required by the law and the adequacy for
human consumption, as required by the Comite´ Etico de
Investigacio´n Clı´nica, was certified. Because of manufacturing
and logistic (storage) limitations, participants could not be
randomly assigned at the start and thus, subjects consumed
consecutively 2 £ 250 ml/d vitamin C-fortified juices supplied
as fruit juice, fruit juice containing milk (skimmed milk
powder) and fruit juice containing milk and iron (Table 1).
In addition, because of these constraints, juices had to be pre-
pared on different occasions so that the carotenoid content
could be eventually not equivalent (especially for the juices
containing milk and iron), probably due to a different ripeness
degree of the fruits used.
All participants were required to have biochemical profile
and serum levels of vitamins A and E and carotenoids
within accepted reference ranges, whereas exclusion criteria
included the use of vitamin and/or herbal supplements, diet-
ing, chronic medication, or intercurrent disease or infection
that could alter the bioavailability or the status of the com-
pounds of interest. No other changes were made in the diet
or lifestyle of the participants except that they should avoid
the consumption of the fruits, or similar, contained in the
juices (i.e. orange, mandarin, grapes, peach, apricot). Subjects
were asked to keep a record of their diets to check the compli-
ance with these dietary recommendations.
Overnight fasting blood samples were collected before and
after each supplementation period for analysis of vitamin E
and carotenoids. The study protocol was approved by the
Comite´ Etico de Investigacio´n Clı´nica of the Hospital Univer-
sitario Puerta de Hierro, and all subjects were informed and
gave their signed consent.
Standards and reagents
Unless otherwise stated, all reagents and materials used in the
in vitro protocol and analysis of blood samples for vitamins A
and E and carotenoids were purchased from Sigma (Madrid,
Spain), VWR Internacional Eurolab (Mollet del Valle´s,
Spain) and Carlo Erba (Madrid, Spain). Zeaxanthin was
generously supplied by DMS (formerly Hoffmann-La Roche,
Basel, Switzerland).
In vitro digestion
To assess the in vitro bioaccessibility of carotenoids and
a-tocopherol from fruit juices in the presence of absorption
modifiers, a static gastrointestinal digestion model previously
applied to fruits and vegetables was used(29). At each step of
the digestion (food, gastric, duodenal and micellar), aliquots
(1 ml) were collected in duplicate, extracted before and after
chemical (KOH) hydrolysis, and analysed by HPLC(30).
Phytochemical analysis
For vitamins A, E (a-tocopherol) and carotenoid analysis in
serum, samples were processed as described elsewhere(30).
Briefly, 0·5 ml serum was mixed with 0·5 ml ethanol containing
internal standard (retinyl acetate), vortexed, and extracted twice
with 2 ml methylene chloride–hexane (1:5). Organic phases
were pooled, evaporated to dryness, and reconstituted to be
injected (tetrahydrofuran–ethanol) on to the high-performance
liquid chromatograph. The chromatographic system consisted
Table 1. Composition of fruit juices (FJ) used in the human study*
Type of juice
Lutein
(mg/100 ml)
Zeaxanthin
(mg/100 ml)
b-Cryptoxanthin
(mg/100 ml)
b-Carotene
(trans-)
(mg/100 ml)
a-Tocopherol
(mg/100 ml)
L-Ascorbic acid
(mg/100 ml)†
Milk
(%)†
Iron
(mg/100 ml)†
FJ 30 70 72 58 477 0·054 None None
FJþmilk 35 60 71 53 484 0·054 11 % None
FJþmilkþiron 18 18 38 38 360 0·054 11 % 3 mg
* Orange, peach, grape juice; carotenoid and a-tocopherol content in saponified extracts.
† Information supplied by the manufacturer (Hero S.A.); percentage of milk in the final product; iron sulphate (II) added to the product.
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of a Spheri-5-ODS column (Applied Biosystems, San Jose, CA,
USA) with gradient elution of acetonitrile–methanol (85:15) for
5 min to acetonitrile–methylene chloride–methanol (70:20:10)
for 20 min. Ammonium acetate (0·025 M) was added to the
methanol. Detection was carried out by a photodiode array
(Model 2996; Waters Associates, Milford, MA, USA) set at
294 nm for tocopherols and 450 nm for carotenoids. Using this
method, a-tocopherol, trans-lutein, zeaxanthin, 13/15-cis-
lutein, a-carotene, all-trans-b-carotene, 9-cis-b-carotene and
13/15-cis-b-carotene, among other carotenoids, can be deter-
mined simultaneously. Identification of compounds was carried
out by comparing retention times with those of authentic stan-
dards and on-line UV–visible spectra.
Samples from each individual (obtained before and after
the intervention) were analysed on the same day to reduce
analytical variability. The short- and long-term precision and
accuracy of the analytical method was verified periodically
through our participation in the Fat-Soluble Quality Assurance
Program conducted by the National Institute of Standards and
Technology (Gaithersburg, MD, USA).
Statistics
In order to achieve consistency in the results from the
different in vitro experiments, the parameters evaluated
(i.e. degree of hydrolysis) were expressed as percentages
of the total amounts initially present in the juices (saponified
extracts), and descriptive statistics were used (means and
95 % CI). In vitro results were interpreted on the basis
of data from crude and saponified extracts. For in vivo
studies, since most of the parameters showed normal distri-
butions, differences in serum concentrations at baseline and at
the end of each intervention period, within-subject variation
due to the juice consumption (paired data) and differences due
to the type of juice were assessed using parametric methods
(ANOVA and post hoc Scheffe´ test, paired t test). However,
because some carotenoid distributions did not fit the normality
criteria, comparisons were also performed using non-parametric
tests (Wilcoxon signed ranks and Kruskal–Wallis test). Statis-
tical significance was set at P,0·05, and the calculations
were performed with SPSS version 8.0 statistical software for
Windows (SPSS Inc., Chicago, IL, USA).
Results
In vitro bioaccessibility
Overall, compared to fruit juice (reference), the extent of
xanthophyll ester hydrolysis (i.e. b-cryptoxanthin, lutein,
zeaxanthin) and the amount of free xanthophylls and a-toco-
pherol transferred into the micellar phase was only signifi-
cantly higher in the presence of milk (Table 2).
In vivo bioavailability
Baseline serum levels of carotenoids, a-tocopherol and reti-
nol were not different at the start of each intervention period
(Table 3). Regardless of the type of juice consumed, con-
sumption of each type of fruit juice provoked significant
increments (within-subject) in the serum levels of a-toco-
pherol and most, but not all, of the carotenoids provided
(Table 4), although the degree of the changes (net incre-
ments) varied according to the type of juice consumed,
as expected given the different carotenoid and tocopherol
content in the juices (see Table 1). However, dose-adjusted
increments (net increment divided by the content in 100 ml
juice) of carotenoids in serum were not significantly higher
when subjects consumed juices with milk and milkþiron
(Fig. 1; Table 4).
Discussion
Food and host-related factors influence carotenoid and
tocopherol bioavailability(8,9). Recently, the release of caro-
tenoids from the food matrix, the solubility, the measure-
ment and interpretation of plasma response, and the
differences in inter-individual response have been referred
to as the challenges to understanding and measuring carote-
noid bioavailability(31). To cover all these aspects, in the
present study we use a complementary approach to assess
Table 2. Ester hydrolysis (% of free forms in the duodenal phase) and bioaccessibility (% of free forms in the micellar phase) of carotenoids and
a-tocopherol under in vitro conditions†
(Mean values and 95 % confidence intervals)
Lutein (%) Zeaxanthin (%) b-Cryptoxanthin (%) Trans-b-carotene (%) a-Tocopherol (%)‡
Type of juice Mean 95 % CI Mean 95 % CI Mean 95 % CI Mean 95 % CI Mean 95 % CI
FJ§ 100 100 100 100 100
Duodenal phasek 29 11, 47 19 14, 24 34 31, 36 101 89, 114 89 78, 100
Micellar phasek 26 18, 33 18 14, 22 30 22, 38 57 43, 71 84 70, 98
FJþmilk§ 100 100 100 100 100
Duodenal phasek 32 29, 36 31* 27, 35 51* 46, 56 106 95, 117 116 89, 140
Micellar phasek 41* 28, 55 39* 24, 55 55* 35, 75 75 38, 111 110* 73, 145
FJþmilkþiron§ 100 100 100 100 100
Duodenal phasek 29 22, 37 28* 20, 35 36 28, 45 85 51, 118 99 47, 150
Micellar phasek 29 14, 44 25 6, 44 38 14, 63 59 47, 70 98 89, 107
FJ, fruit juice.
Mean values were significantly different from those of the FJ group (ANOVA and Scheffe´ post hoc test): *P,0·05.
† For details of procedures and diets, see the Subjects and methods section and Table 1.
‡ For a-tocopherol, values referred to the percentage of recovery in each digestion phase (no ester forms were present).
§ Total content in saponified extracts (used as reference values ¼ 100 %).
kPercentage of free forms (unsaponified extracts) against total content (saponified extracts).
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Table 3. Serum levels of carotenoids and a-tocopherol at the start of each intervention period (n 32)*
(Mean values and 95 % confidence intervals)
Lutein (mmol/l) Zeaxanthin (mmol/l)
b-Cryptoxanthin
(mmol/l)
Trans-b-carotene
(mmol/l) a-Tocopherol (mmol/l) Retinol (mmol/l)
Type of juice Mean 95 % CI Mean 95 % CI Mean 95 % CI Mean 95 % CI Mean 95 % CI Mean 95 % CI
FJ 0·23 0·19, 0·26 0·04 0·03, 0·05 0·43 0·31, 0·56 0·34 0·26, 0·43 20·9 19·6, 22·2 1·64 1·47, 1·78
FJþmilk 0·25 0·21, 0·30 0·05 0·04, 0·06 0·38 0·31, 0·43 0·34 0·26, 0·39 21·5 19·9, 23·0 1·75 1·61, 1·92
FJþmilkþiron 0·26 0·21, 0·30 0·06 0·04, 0·07 0·36 0·31, 0·40 0·34 0·28, 0·41 21·8 20·5, 23·1 1·75 1·57, 1·89
Differences between
baseline levels†
NS NS NS NS NS NS
FJ, fruit juice.
* For details of procedures and diets, see the Subjects and methods section and Table 1.
† ANOVA and Scheffe´ post hoc test.
Table 4. Within-subject net increments (final minus basal) in serum levels of carotenoids and a-tocopherol upon consumption of fruit juices (FJ)‡
(Mean values and 95 % confidence intervals)
Lutein (mmol/l) Zeaxanthin (mmol/l) b-Cryptoxanthin (mmol/l) Total b-carotene (mmol/l) a-Tocopherol (mmol/l)
Type of juice Mean 95 % CI Mean 95 % CI Mean 95 % CI Mean 95 % CI Mean 95 % CI
FJ þ0·012 20·014, 0·038 þ0·060*† 0·044, 0·076 þ0·123*† 0·067, 0·179 þ0·060*† 0·022, 0·097 1·65*† 0·23, 3·04
FJþmilk þ0·009 20·014, 0·032 þ0·062*† 0·049, 0·076 þ0·147*† 0·109, 0·184 þ0·052*† 0·022, 0·082 þ0·72† 20·28, 1·70
FJþmilkþiron þ0·004 20·012, 0·019 þ0·021*† 0·011, 0·032 þ0·090*† 0·058, 0·123 þ0·019 20·015, 0·054 þ1·04*† 0·51, 1·58
Differences in the increments
(dose-adjusted) according
to the type of juice§
NS NS NS NS NS
Mean values were significantly different from those of the FJ group (paired t test): *P,0·05.
Mean values were significantly different from those of the FJ group (Wilcoxon signed ranks test): †P,0·05.
‡ For details of procedures and diets, see the Subjects and methods section and Table 1.
§ ANOVA, Dunnett post hoc test and Kruskal–Wallis test.
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the effect of absorption modifiers (milk-derived peptides
and iron) on the bioaccessibility (in vitro) and bioavaila-
bility (in vivo response) of carotenoids and a-tocopherol
from fruit juices.
In vitro methods may be appropriate for studying pre-
absorptive processes, although their validity as an index of
absorbability and/or bioavailability should be validated in
different in vivo situations(5,7). In the present study, in vitro
data showed that the degree of ester hydrolysis of xantho-
phylls (i.e. b-cryptoxanthin and zeaxanthin) increased in the
presence of milk, an effect that is also observed during the
transference into the micellar phase. Since the presence of
free forms in the micellar phase may be indicative of the
maximum amount available for absorption(3,5,9,29) based on
the present results, a higher serum response after consumption
of juices with modifiers could be expected. However, in the
in vivo study, regular consumption of these juices provoked
significant increments (within-subject) regardless of the type
of juice consumed, suggesting that the presence of milk and
milk plus iron (at the levels used in the present study) did
not compromise the bioavailability of carotenoids and a-toco-
pherol from fruit juices. Moreover, although the presence of
milk appeared to improve the serum response for some
(i.e. b-cryptoxanthin) but not all carotenoids, this enhan-
cing effect was not significant and thus, the agreement
between in vitro and in vivo results should be considered
suggestive but not fully concordant. On the contrary, for
a-tocopherol, the in vitro and in vivo results were inconsistent
since the juice with the apparently higher in vitro bioacces-
sibility (fruit juice with milk) showed the lowest serum
response in vivo. Nevertheless, the present results agree
with previous observations regarding the variability of
in vitro bioaccessibility for different carotenoids in a given
food(14,32) and concerning the different behaviour of distinct
carotenoids and tocopherols in a food under in vitro and
in vivo conditions(6,33).
It has been suggested that casein phosphopeptides could
inhibit lipid oxidation by chelation and non-chelating mechan-
isms such as free radical scavenging(23,24). In the present
study, although the magnitude of effect observed may be of
little relevance, it appears to be associated with the presence
of milk and/or milk-derived peptides rather than related to
antioxidant mechanisms(22) since the three types of juice con-
tained the same amounts of ascorbic acid. Also, it is known
that the presence of fat may improve bioavailability through
different mechanisms including digestive enzyme activities
and micelles formation(5,8). However, in the present study,
the type of milk incorporated into the juices was fat-free
milk and thus differences in the amount of fat, if any,
should be negligible. Also, it has been reported that milk
caseins stabilize calcium and phosphate ions and that
tryptic digestion of casein yields casein phosphopeptides that
may interact between caseins and calcium phosphate in
the formation of casein micelles, thus enhancing mineral
bioavailability(22). Thus, although we have not assessed
casein phosphopeptides under the conditions assayed, a bene-
ficial physico-chemical effect in the system (i.e. mineral
chelation, phosphate-induced negative charges and effect on
solubility and micelles surface, stabilization of micelles)
cannot be ruled out.
Finally, the predictive value of the in vitro models relies
on the consistency between the results under simulated con-
ditions and those observed in vivo under different physio-
logical conditions(4,5,7), although comparisons are often
difficult since both approaches lack standardization par-
ameters or traceability to reference methods(34). In the pre-
sent study, in vitro and in vivo results appear to be not
consistent since under in vivo conditions the enhancing
effect of absorption modifiers on carotenoid bioavailability
did not reach statistical significance. In vivo (human) data
constitute the reference standard (‘true response’) while
in vitro methods are used as surrogates for prediction.
However, we should be aware that the in vivo (human)
model also displays its own methodological and biological
constraints and uncertainties (i.e. first-pass metabolism,
intracellular regulation, homeostatic control). For instance,
Fig. 1. Dose-adjusted increments in serum of b-cryptoxanthin (X) and zea-
xanthin (W) (a), and b-carotene (W) and lutein (X) (b), after regular consump-
tion (21 d) of each type of fruit-based juice. Values are means with 95 % CI
depicted by vertical bars.
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dose-adjusted responses may compensate the different intake of
some compounds but this approach cannot cancel out a different
relative contribution within a given diet or the timing of the
intervention. Thus, a lack of agreement may not necessarily
mean inadequacy of the in vitro approach since a full concor-
dance between in vitro data and in vivo response may not be
expected(6,33).
In conclusion, the presence of milk or milk-derived peptides
(i.e. casein phosphopeptides) and milk plus iron in fruit juices
do not influence the bioavailability of carotenoids and a-toco-
pherol from fruit juices. The present results support the use
of in vitro models to assess food-related factors affecting
bioavailability of carotenoids and tocopherols from foods
although in vivo and methodological factors may limit their
comparability and predictive value.
Acknowledgements
This work was funded by AGL2004-07 657-C02-02 (Minis-
terio de Educacio´n y Ciencia, Spain). F. G.-L. and B. O.-A.
had the responsibility for designing the study; C. H.-B., B.
P.-S. and I. B.-N. performed the in vitro experiments,
follow-up of the volunteers and serum analysis; F. G.-L. and
C. H.-B. carried out the statistical analysis and wrote the
manuscript. There are no conflicts of interest.
References
1. World Health Organization (2003) Diet, Nutrition and the
Prevention of Chronic Diseases. Joint WHO/FAO Expert Con-
sultation. WHO Technical Report Series no. 916. Geneva:
WHO.
2. Olmedilla B, Granado F & Herrero C (2001) Dieta Mediterra´nea
frente a suplementacio´n con micronutrientes: pros y contras.
Rev Chilena Nutr 28, 368–380.
3. During A & Harrison EH (2004) Intestinal absorption
and metabolism of carotenoids: insights from cell culture.
Arch Biochem Biophys 430, 77–88.
4. Yun S, Habitch JP, Miller DD & Glahn RP (2004) An in vitro
digestion/Caco-2 cell culture system accurately predicts the
effects of ascorbic acid and polyphenolic compounds on iron
bioavailability in humans. J Nutr 134, 2717–2721.
5. Failla M & Chitchumroonchokchai C (2005) In Vitro Models as
Tools for Screening the Relative Bioavailabilities of Provitamin
A Caroteniods in Fools. Technical Monographs Series no. 3.
Washington, DC: Harvest Plus.
6. Reboul E, Richelle M, Perrot E, Desmoulins-Mazelet C, Pirisi V
& Borel P (2006) Bioaccessibility of carotenoids and vitamin E
from their main dietary sources. J Agric Food Chem 54,
8749–8755.
7. Oomen A, Hack A, Minekus M, et al. (2002) Comparison
of five in vitro digestion models to study the bioaccessibility
of soil contaminants. Environ Sci Technol 36, 3326–3334.
8. West CE & Castenmiller JJ (1998) Quantification of the ‘SLA-
MENGHI’ factors for carotenoid bioavailability and bioconver-
sion. Int J Vitam Nutr Res 68, 371–377.
9. Borel P (2003) Factors affecting intestinal absorption of
highly lipophilic food microconstituents (fat-soluble vitamins,
carotenoids and phytosterols). Clin Chem Lab Med 41,
979–994.
10. Borel P, Tyssandier V, Mekki N, et al. (1998) Chylomicron
b-carotene and retinyl palmitate responses are dramatically
diminished when men ingest b-carotene with medium-
chain rather that long-chain triglycerides. J Nutr 128, 1361–1367.
11. Roodemburg AJ, Leenen R, van het Hof KH, Weststrate JA &
Tijburg LB (2000) Amount of fat in the diet affects bioavailabi-
lity of lutein esters but not of alpha-carotene, beta-carotene, and
vitamin E in humans. Am J Clin Nutr 71, 1029–1030.
12. Richelle M, Enslen M, Hager C, et al. (2004) Both free and
esterified plant sterols reduce cholesterol absorption and the
bioavailability of b-carotene and a-tocopherol in normocholes-
terolemic humans. Am J Clin Nutr 80, 171–177.
13. Riedl KM, Hoffman J & Wolfram G (1999) Some dietary fibers
reduce the absorption of carotenoids in women. J Nutr 129,
2170–2176.
14. Granado-Lorencio F, Olmedilla-Alonso B, Herrero-Barbudo C,
Pe´rez-Sacrista´n B, Blanco-Navarro I & Bla´zquez-Garcı´a S
(2007) Comparative in vitro bioaccessibility of carotenoids
from relevant contributors to carotenoid intake. J Agric Food
Chem 55, 6387–6394.
15. Jacobs PB, LeBoeuf RD, McCommas SA & Tauber JD (1982)
The cleavage of carotenoid esters by cholesterol esterase. Comp
Biochem Physiol B Biochem Mol Biol 72, 157–160.
16. Hedren E, Mulokozi G & Svanberg U (2002) In vitro accessibi-
lity of carotenes from green leafy vegetables cooked with sun-
flower oil or red palm oil. Int J Food Sci Nutr 53, 445–453.
17. Tyssandier V, Reboul E, Dumas J, Bouteloup-Demange C,
Armand M, Marcand J, Sallas M & Borel P (2003) Proces-
sing of vegetable-borne carotenoids in the human stomach
and duodenum. Am J Physiol Gastrointest Liver Physiol 284,
G913–G923.
18. Serrano J, Gon˜i I & Saura-Calixto F (2005) Determination of
b-carotene and lutein available from green leafy vegetables by
an in vitro digestion and colonic fermentation method. J Agric
Food Chem 53, 2936–2940.
19. Yonekura L, Tsuzuki W & Nagao A (2006) Acyl moieties
modulate the effects of phospholipids on b-carotene uptake by
Caco-2 cells. Lipids 41, 629–636.
20. Jiang Q, Cristen S, Shigenaga MK & Ames BN (2001) g-Toco-
pherol, the major form of vitamin E in the US diet, deserves
more attention. Am J Clin Nutr 74, 14–22.
21. Stahl W & Sies H (2005) Bioactivity and protective effects of
natural carotenoids. Biochim Biophys Acta 1740, 101–107.
22. Hartman R & Meisel H (2007) Food-derived peptides with
biological activity: from research to food applications. Curr
Opin Biotechnol 18, 163–169.
23. Kim G-N, Jang H-D & Kim Ch-I (2007) Antioxidant capacity of
caseinophosphopeptides prepared from sodium caseinate using
Alcalase. Food Chem 104, 1359–1365.
24. Kitts DD (2005) Antioxidant properties of caseinphosphopep-
tides. Trends Foods Sci Technol 16, 549–554.
25. Meisel H & FitzGerald RJ (2003) Biofunctional peptides from
milk proteins: mineral binding and cytomodulatory effects.
Curr Pharm Des 9, 1285–1295.
26. Hartman R & Meisel H (2004) Caseinphosphopeptides and their
cell modulating potential. Biofactors 21, 73–78.
27. Teucher B, Majsak-Newman G, Dainty JR, McDonagh D, FitzGer-
ald RJ & Fairweather-Tait SJ (2006) Calcium absorption is not
increased by caseinphosphopeptides. Am J Clin Nutr 84, 162–164.
28. FitzGerald RJ & Meisel H (2003) Caseinphosphopeptides
(CPPs) as functional ingredients. In Functional Dairy Products,
pp. 187–202 [T Mattila-Sandholm and M Saarela, editors].
Cambridge, UK: Woodhead Publishing.
29. Granado-Lorencio F, Olmedilla-Alonso B, Herrero-Barbudo
C, Blanco-Navarro I, Pe´rez-Sacrista´n B & Bla´zquez-Garcı´a S
(2007) In vitro bioaccessibility of carotenoids and tocopherols
from fruits and vegetables. Food Chem 102, 641–648.
30. Olmedilla B, Granado F, Gil-Martinez E, Blanco I & Rojas-
Hidalgo E (1997) Reference levels of retinol, a-tocopherol
Bioavailability and absorption modifiers 581
B
ri
ti
sh
Jo
u
rn
al
o
f
N
u
tr
it
io
n
and main carotenoids in serum of control and insulin-dependent
diabetic Spanish subjects. Clin Chem 43, 1066–1071.
31. Faulks RM & Southon S (2005) Challenges to understanding
and measuring carotenoid bioavailability. Biochim Biophys
Acta 170, 95–100.
32. O’Connell OF, Ryan L & O’Brien NM (2007) Xanthophyll
carotenoids are more bioaccessible from fruits than dark green
vegetables. Nutr Res 27, 258–264.
33. Granado F, Olmedilla B, Herrero C, Pe´rez-Sacrista´n B, Blanco I
& Bla´zquez S (2006) Bioavailability of lutein, b-carotene and
tocopherols from broccoli: in vivo and in vitro assessment.
Exp Biol Med 231, 1733–1738.
34. Granado-Lorencio F, Olmedilla-Alonso B, Herrero-Barbudo C,
Pe´rez-Sacrista´n B & Blanco-Navarro I (2007) In vitro and in vivo bio-
availability of carotenoids and tocopherols from fruits and vegetables:
a complementary approach. Int J Biobmed Pharm Sci 1, 46–59.
F. Granado-Lorencio et al.582
B
ri
ti
sh
Jo
u
rn
al
o
f
N
u
tr
it
io
n
